Sequist, L.Gray, J.Harb, W.Doebele, R.Modiano, M.Jackman, D.Baggstrom, M.Atmaca, A.Felip, E.Provencio, M.Cobo Dols, M.Adiwijaya, B.Kuesters, G.Kamoun, W.Andreas, K.Pipas, J.Santillana, S.Cho, B. C.Park, K.Shepherd, F.2025-01-072025-01-072018-10-011556-0864https://hdl.handle.net/10668/24369enbiomarkerSeribantumabHeregulinRandomized Phase 2 Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancerconference outputopen access10.1016/j.jtho.2018.08.8931556-1380http://www.jto.org/article/S1556086418318513/pdf454014502048